Increased reporting of venous and arterial thromboembolic events reported with tixagevimab-cilgavimab for coronavirus disease 2019Observational Study Published on 2023-04-012023-07-10 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), [키워드] Arterial thromboembolic events COVID-19 Myocardial infarction pharmacovigilance Pulmonary embolism Tixagevimab–cilgavimab VigiBase. [DOI] 10.1016/j.cmi.2022.11.026 PMC 바로가기 [Article Type] Observational Study
Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospitalArtículo Original Published on 2023-03-282024-09-05 Journal: Revista peruana de medicina experimental y salud pública [Category] update2024, [키워드] Azithromycin Azitromicina COVID-19 Farmacovigilancia Hidroxicloroquina Hydroxychloroquine Ivermectin Ivermectina pharmacovigilance Tocilizumab [DOI] 10.17843/rpmesp.2023.401.11563 PMC 바로가기 [Article Type] Artículo Original
Vulval Aphthous Ulcers in Adolescents Following COVID-19 Vaccination—Analysis of an International Case SeriesArticle Published on 2023-03-172024-09-05 Journal: Journal of pediatric and adolescent gynecology [Category] update2024, [키워드] adolescents Bradford Hill criteria Case series COVID-19 vaccine Lipschütz ulcers patient safety pharmacovigilance Vulval aphthous ulcers [DOI] 10.1016/j.jpag.2023.03.006 PMC 바로가기 [Article Type] Article
French pharmacovigilance survey of casirivimab – imdevimab monoclonal antibodies in coronavirus disease (COVID-19)Pharmacovigilance Published on 2023-02-222024-09-05 Journal: Thérapie [Category] update2024, [키워드] Adverse drug reaction Casirivimab imdevimab COVID-19 monoclonal antibodies pharmacovigilance Pharmacovigilance survey Ronapreve SARS-CoV-2 [DOI] 10.1016/j.therap.2023.02.004 PMC 바로가기 [Article Type] Pharmacovigilance
Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?Pharmacovigilance Published on 2023-02-222024-09-05 Journal: Thérapie [Category] update2024, [키워드] adverse effect COVID-19 vaccine Détection de signal Drug safety Effet indésirable pharmacovigilance Sécurité des médicaments signal detection Vaccin COVID-19 [DOI] 10.1016/j.therap.2023.02.009 PMC 바로가기 [Article Type] Pharmacovigilance
Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases seriesPharmacovigilance Published on 2023-02-162024-09-05 Journal: Thérapie [Category] update2024, [키워드] adverse effect COVID-19 vaccine Drug safety peripheral facial palsy pharmacovigilance [DOI] 10.1016/j.therap.2023.02.005 PMC 바로가기 [Article Type] Pharmacovigilance
Thrombotic events following the BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech) in Aotearoa New Zealand: A self-controlled case series studyArticle Published on 2023-02-012023-07-11 Journal: Thrombosis research [Category] COVID19(2023년), [키워드] COVID-19 mRNA vaccines pharmacoepidemiology pharmacovigilance thrombosis [DOI] 10.1016/j.thromres.2022.12.012 PMC 바로가기
Anti-glomerular Basement Membrane Disease Concomitant with MPO-ANCA Positivity Concurrent with High Serum Levels of Interleukin-26 Following Coronavirus Disease 2019 VaccinationCase Report Published on 2023-02-012024-09-05 Journal: Internal medicine (Tokyo, Japan) [Category] update2024, [키워드] ANCA-associated glomerulonephritis Anti-GBM disease IL-26 mRNA-based COVID-19 vaccine pharmacovigilance [DOI] 10.2169/internalmedicine.1027-22 PMC 바로가기 [Article Type] Case Report
COVID-19 vaccines adverse events: potential molecular mechanismsReview Published on 2023-01-062024-09-04 Journal: Immunologic research [Category] 대상포진, [키워드] Adverse drug reactions adverse events COVID-19 vaccines mechanisms pharmacovigilance Side effects [DOI] 10.1007/s12026-023-09357-5 PMC 바로가기 [Article Type] Review
Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccessarticle Published on 2022-11-302024-09-02 Journal: Human vaccines & immunotherapeutics [Category] 대상포진, [키워드] Adverse events following immunization COVID-19 vaccines pharmacovigilance spontaneous reporting VigiAccess [DOI] 10.1080/21645515.2022.2109365 PMC 바로가기 [Article Type] article